![[PRC HOME]](images/hivribbon.gif) |
|
 |
 |
|
|
 |
 |
|
 |
 |
 |
| |
Dosing of Antiretrovirals in Renal Impairment
NRTI/NtRTI |
Drug |
CrCl (ml/min) |
Weight (kg) |
Dose |
didanosine (EC tabs) |
≥60 |
≥60 |
400mg EC qd |
30-59 |
200mg EC qd |
10-29 |
125mg EC qd |
<10 |
125mg EC qd |
≥60 |
<60 |
250mg EC qd |
30-59 |
125mg EC qd |
10-29 |
125mg EC qd |
<10 |
contraindicated |
didanosine buffered powder for oral soln |
≥60 |
≥60 |
250mg q 12 h |
30-59 |
100mg q 12 h |
10-29 |
167mg q 24 h |
<10 |
100mg q 24 h |
≥60 |
<60 |
167mg q 12 h |
30-59 |
100mg q 12 h |
10-29 |
100mg q 24 h |
<10 |
100mg q 24 h |
Emtricitabine |
≥50 |
any |
200mg qd |
30-49 |
200mg q 48 h |
15-29 |
200mg q 72 h |
<15 |
200mg q 96h |
Lamivudine |
≥50 |
any |
150mg bid or 300mg qd |
30-49 |
150mg qd |
15-29 |
150mg dose 1, then 100mg qd |
5-14 |
150mg dose 1, then 50mg qd |
<5 |
50mg dose 1, then 25mg qd |
Stavudine |
>50 |
≥60 |
40mg bid |
26-50 |
20mg bid |
10-25 |
20mg qd |
>50 |
<60 |
30mg bid |
26-50 |
15mg bid |
10-25 |
15mg qd |
Tenofovir |
≥50 |
any |
300mg qd |
30-49 |
300mg q 48 h |
10-29 |
300mg biw |
Zalcitabine |
10-40 |
any |
0.75mg po bid |
<10 |
0.75mg po qd |
Zidovudine |
<15 |
any |
100mg po tid |
Emtricitabine/tenofovir |
≥50 |
any |
1 tab po qd |
30-49 |
1 tab po q 48 h |
<30 |
use component drugs |
|
 |
|
| |

|